Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hovig

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Mutation Research|January 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionE Hovig, B Smith-Sørensen, A Brøgger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2002
CA 125: the end of the beginningE Hovig, P D Rye, D J Warren, et al.
Cancer Genetics and Cytogenetics|December 1, 1992
A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomasE Hovig, A Andreassen, B M Fangan, et al.
Mutation Research|September 1, 1992
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)B Smith-Sørensen, E Hovig, B Andersson, et al.
American Journal of Human Genetics|August 12, 1999
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerA Dørum, K Heimdal, E Hovig, et al.
Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Chromosome 13 instability and esterase D expression in an osteosarcoma cell lineE Hovig, J O Winberg, O Fodstad, et al.
Human Genetics|March 10, 1999
Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53A I Wacey, D N Cooper, D Liney, et al.
Disease Markers|December 14, 1999
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsA Borg, A Dørum, K Heimdal, et al.
Genomics|July 1, 1993
Genome scanning of human breast carcinomas using micro- and minisatellite core probesE Hovig, E Mullaart, A L Børresen, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Mutation Research|January 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionE Hovig, B Smith-Sørensen, A Brøgger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2002
CA 125: the end of the beginningE Hovig, P D Rye, D J Warren, et al.
Cancer Genetics and Cytogenetics|December 1, 1992
A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomasE Hovig, A Andreassen, B M Fangan, et al.
Mutation Research|September 1, 1992
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)B Smith-Sørensen, E Hovig, B Andersson, et al.
American Journal of Human Genetics|August 12, 1999
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerA Dørum, K Heimdal, E Hovig, et al.
Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Chromosome 13 instability and esterase D expression in an osteosarcoma cell lineE Hovig, J O Winberg, O Fodstad, et al.
Human Genetics|March 10, 1999
Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53A I Wacey, D N Cooper, D Liney, et al.
Disease Markers|December 14, 1999
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsA Borg, A Dørum, K Heimdal, et al.
Genomics|July 1, 1993
Genome scanning of human breast carcinomas using micro- and minisatellite core probesE Hovig, E Mullaart, A L Børresen, et al.
Pageof 6